<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 01-Aug-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (01-Aug-2025)</h1>
<hr />
<h2>Key News Events (Summary Bullets)</h2>
<ul>
<li><strong>Tariff Shock:</strong> Trump administration imposes new global tariff rates effective Aug. 7, with broad increases (notably 35% on Canada), and 40% on transshipped goods—trade partners begin reacting, raising threat of retaliation and shifts in supply chains.</li>
<li><strong>Apple and Amazon Earnings:</strong> Apple beats revenue estimates but faces projected $1.1B in annual tariff costs; Amazon posts solid results but guides lower as AI/data center capex weighs on profitability.</li>
<li><strong>Figma IPO Surge:</strong> Figma shares more than triple on debut, suggesting strong risk appetite/valuation potential for select software and tech IPOs.</li>
<li><strong>Severe Weather:</strong> Flash flooding and storm disruptions in New York/New Jersey and Texas highlight growing frequency of natural disasters for insurers, utilities, and real estate sectors.</li>
<li><strong>US Jobs Report Looming:</strong> Market awaits July employment report after several days of market softness as tariff deadlines and macro uncertainty build.</li>
<li><strong>Other:</strong> CDC warns on record-low childhood vaccination rates; new Legionnaires’ outbreak in NYC; Zelensky reverses anti-corruption move in Ukraine; SpaceX Crew-11 launch scrubbed due to weather.</li>
</ul>
<hr />
<h2>Broad Macro and Global Themes</h2>
<h3>1. US Macro &amp; Policy Direction</h3>
<ul>
<li><strong>Trade:</strong> The new, widespread tariffs mark a dramatic escalation of US protectionism. Major partners (Canada, Mexico, EU, Japan, China, South Korea) directly targeted. Expect immediate supply chain shifts (reshoring, friend-shoring, and evasive transshipping maneuvers), cost pass-through, and inflationary pressures—especially in auto, industrials, consumer, and electronics. Potential for tit-for-tat retaliation.</li>
<li><strong>Inflation &amp; Rates:</strong> While core inflation and CPI show moderate momentum (trending toward 3%), tariffs could reverse recent progress, pressuring the Fed to maintain a tighter stance for longer. Real wage gains look marginally positive, but cost-push inflation risks are rising.</li>
<li><strong>Labor Market:</strong> Unemployment remains contained (soft landing remains consensus), but significant upside risk to unemployment over the next several years persists—key to watch if higher input costs begin to impact corporate hiring.</li>
<li><strong>Fiscal/Debt:</strong> Rising government spending and debt issuance will continue, regardless of near-term efforts at deficit reduction. Tariffs may buoy receipts temporarily, but real debt and budget pressures (especially with potential for &quot;Trump Boom&quot; stimulus) remain a risk for long-dated Treasuries.</li>
<li><strong>Recession Risk:</strong> Probability of an outright US recession in 2025/26 is still low, but risks increase post-tariff escalation, especially if foreign demand or confidence erodes.</li>
</ul>
<h3>2. Global Macro</h3>
<ul>
<li><strong>EU:</strong> No major EU exit votes impending through 2030, but weak probability of member loss (Hungary/Italy) and strong odds of EU expansion; currency risk from political frictions remains secondary.</li>
<li><strong>China:</strong> China overtaking US GDP by 2030 is possible but not likely; lower odds for outright recession vs. developed peers, but still meaningful. Tariff escalation damages short-term Chinese export/growth outlook—expect stimulus responses or tit-for-tat retaliation.</li>
<li><strong>Geopolitics:</strong> Middle East (Iran) succession risk not imminent but rising. Ukraine/Russia ceasefire/losses unlikely this year, so little near-term impact on global commodities. Elevated but still low risk of a nuclear incident.</li>
<li><strong>Natural Catastrophe:</strong> California/Japan earthquake risk present but low for near-term (&lt;5 years), but ongoing storms/floods reinforce need for caution in insurance/utility/real estate exposure.</li>
</ul>
<hr />
<h2>Sectors: Second-Order Effects</h2>
<h3>1. Industrials &amp; Trade-Sensitive Sectors</h3>
<ul>
<li><strong>Global supply chains &amp; logistics:</strong> Multi-country tariffs and 40% on transshipped goods disrupt established routes, driving costs up and shifting sourcing strategies for OEMs and retailers. Near-term pain for importers/exporters, and potential windfall for US-based manufacturers.</li>
<li><strong>Industrials/Manufacturers:</strong> Input cost inflation likely, potential for select &quot;reshoring&quot; winners but margin pressure otherwise.</li>
<li><strong>Autos &amp; Components:</strong> Directly in the tariff crosshairs—watch for consumer price hikes, margin pressure, and likely acceleration in localization and North American content.</li>
<li><strong>Agriculture &amp; Commodities:</strong> Tariff moves may generate both volatility and opportunities for pockets of US ag, but also risk of export market closures and overhang from possible retaliation.</li>
</ul>
<h3>2. Technology &amp; Communications</h3>
<ul>
<li><strong>Big Tech Antitrust:</strong> Courts are increasingly likely to deliver monopoly rulings against Amazon, Apple, Live Nation. Long-term, this could force structural changes or regulation (splits, divestitures, platform neutrality).</li>
<li><strong>AI Regulation &amp; Liability:</strong> Significant odds of US government intervention in AI companies or projects before 2030, and pending lawsuits (e.g., OpenAI/NYT) increase legal and operational risks for leading AI names.</li>
<li><strong>IPO Market:</strong> Signs of speculative risk-on environment with blockbuster Figma debut; strong appetite for high-growth stories (with OpenAI, Stripe, Klarna, Deel watching closely for timing).</li>
<li><strong>CAPEX Drag:</strong> Public cloud and AI infrastructure spending are weighing on profit margins for Amazon and likely other hyperscalers, may support semis and hardware in near-term but raise questions for software multiples if returns on capital disappoint.</li>
<li><strong>Crypto:</strong> Adoption as reserve asset and S&amp;P 500 balance sheet holding is climbing, but odds of major pro-crypto tax moves are low; Fed, CFTC or IRS regulation could still create headline volatility.</li>
</ul>
<h3>3. Healthcare &amp; Life Sciences</h3>
<ul>
<li><strong>Drug Pricing:</strong> US drug price controls are impacting margins (Ozempic, insulin), with the highest probability for moderate near-term cuts and more meaningful falls deferred. Surging payer/policy pressure amplified after pandemic and inflation experience.</li>
<li><strong>Innovation Pipeline:</strong> Near-term FDA approvals (Elinzanetant, Donidalorsen, Sebetralstat) probable—watch smaller biotechs for binary event-driven trades. Less likely, but impactful, prospects for breakthrough cures (e.g., Type 1 diabetes) could disrupt diabetes franchise valuations.</li>
<li><strong>Policy Risk:</strong> Only modest potential for anti-pharma monopoly legislation by 2027; more likely, ongoing pricing and competition pressure.</li>
</ul>
<h3>4. Energy, Oil &amp; Commodities</h3>
<ul>
<li><strong>Tariffs on Critical Commodities:</strong> Copper, industrial metals, and some energy products face higher US tariff risk, impacting mining/exporters in Asia and Americas. Energy transition potential slows; input bottlenecks for renewables possible.</li>
<li><strong>Oil/NatGas Price Outlook:</strong> Whipsaw moves likely. Tariffs and Middle East instability could support spikes, but recession risk and demand destruction could concurrently drive volatility. Nat gas has a high probability of trending above $3 but could be whippy.</li>
<li><strong>Energy Transition:</strong> Coal expected to remain a major global energy source approaching 2030, limiting the odds of a dramatic carbon drop; US solar installation likely, but short of most bullish forecasts.</li>
</ul>
<h3>5. Real Estate, Utilities, Insurance</h3>
<ul>
<li><strong>Severe Weather Risk:</strong> More frequent high-impact events (flash floods, hurricanes, etc.) continue to threaten property/casualty insurance margins and devalue at-risk real estate, especially in coastal cities and California.</li>
<li><strong>California Real Estate:</strong> Catastrophic quake risk remains a long-term tail rather than an immediate concern, but storms/floods are immediate operational and pricing issues across several states.</li>
</ul>
<hr />
<h2>Single-Company/Name-Specific Signals</h2>
<ul>
<li><strong>Apple:</strong> Tariffs to eat into margins, but high pricing power and brand loyalty can soften blow. Strong earnings, but forward multiples likely capped by tariff cost overhang. China exposure remains a wildcard.</li>
<li><strong>Amazon:</strong> AI/infrastructure investments driving revenue and cloud, but compressing near-term profit; antitrust spotlight intensifying.</li>
<li><strong>Nvidia:</strong> Highly likely to retain/prioritize mega-cap leadership and valuation through year-end—semiconductor cycle at its back, but regulation/antitrust threat rising.</li>
<li><strong>Tesla:</strong> Not expected to become world’s largest company soon, but Musk’s wealth concentration continues as “EV share above 30% by 2030” moves closer to consensus. Margins and supply chain risk from tariffs, especially in Asia/Europe.</li>
<li><strong>Live Nation:</strong> Legal and regulatory threats on monopoly status increasingly probable—potential revenue headwind.</li>
<li><strong>SpaceX:</strong> Mars landing is possible but not yet probable by 2030; satellite/Starlink IPOs likely deferred.</li>
<li><strong>Figma:</strong> IPO signals strong demand for high-growth software, setting table for other tech unicorns.</li>
</ul>
<hr />
<h2>Tactical Implications / Watch List</h2>
<ul>
<li><strong>US Multi-nation Tariffs:</strong> Prepare for supply chain/margin disruption in trade-exposed sectors. Near-term winners: North American manufacturing and companies with inelastic demand or import substitution.</li>
<li><strong>Interest Rates:</strong> Higher for longer posture likely unless inflation sharply recedes despite tariffs. Limited tailwinds for long bonds until deficit or CPI trajectory clearly improves.</li>
<li><strong>Big Tech:</strong> Stay alert for anti-monopoly legal actions and AI regulation headlines. Core growth still strong but headline/policy volatility probable.</li>
<li><strong>Volatility Trading:</strong> Ongoing weather, regulatory and geopolitical events argue for keeping option and volatility exposure in central allocation.</li>
<li><strong>Commodities &amp; Energy:</strong> Policy and supply chain risk remain high—consider both upside and downside scenarios for oil, copper, and ag, especially around tariff and geopolitical shocks.</li>
<li><strong>Biotech/Pharma:</strong> Focus on near-term FDA catalysts and pipeline event trades, alongside monitoring continuing pressure on US drug pricing.</li>
</ul>
<hr />
<p><strong>Monitor:</strong> The jobs report, tariff retaliation actions from major US trade partners, additional executive actions, and new antitrust filings or Congressional action in big tech/AI. Potential for short-term volatility and headline-driven opportunity remains high, especially around trade, inflation, and sector rotation themes.</p>

</main>
</body>
</html>
